St. John's wort (Hypericum perforatum) has a history of medicinal use dating back to ancient Greece, where it was used to treat a range of illnesses, including various "nervous disorders." St. John's wort also has antibacterial and antiviral properties and, because of its anti-inflammatory properties, has been used topically to help heal wounds and burns. St. John's wort is one of the most commonly purchased herbal products in the United States.
In recent years, there has been renewed interest in St. John's wort as a treatment for depression and there has been a great deal of scientific research on this topic. In general, most studies have shown that St. John's wort may be an effective treatment for mild-to-moderate depression, and has fewer side effects than most other prescription antidepressants. But the herb interacts with a wide variety of medications, so it is important to take it only under the guidance of a health care provider.
It is also important to note that severe depression (characterized by an inability to function with daily activities, thoughts of suicide or of harming yourself or others) should not be treated with herbs. Always see a doctor if your depression is serious (See "Precautions").
Depression
In numerous studies, St. John's wort has been effective in reducing symptoms in those with mild-to-moderate but not severe (or major) depression. In certain studies it appears to work as well as selective serotonin reuptake inhibitors (SSRIs), a popular type of antidepressant that includes fluoxetine (Prozac), citalopram (Celexa), and sertraline (Zoloft) without one of the most common side effects, loss of libido.
St. John's wort contains several chemicals, including hypericin, hyperforin and flavonoids. Researchers aren't exactly sure how St. John's wort works, although it has been suggested that the herb acts like an SSRI, making more serotonin, dopamine and norepinephrine available to the brain. These neurotransmitters help improve one's mood. Scientists thought that hypericin was responsible for these effects, but now they are beginning to think that other chemicals in St. John's wort are the ones that actually have a beneficial effect.
Not all studies agree, however. In one study, St. John's wort was found to be no more effective than placebo for treating depression; however, in the same study, Zoloft also failed to show any benefit in treating depression. A number of other studies have compared St. John's wort to Prozac, Celexa, paroxetine (Paxil), and Zoloft and found that the herb is just as effective as the drug. Other studies are ongoing.
Other Uses
St. John's wort has also shown promise in treating the following conditions, a few of which are related to depression.
- Bacterial and viral infections: In laboratory studies, St. John's wort has demonstrated the ability to fight certain infections, including some bacteria that are resistant to antibiotics. But it isn't known whether St. John's wort would have the same effect in people.
- HIV infection and AIDS: While laboratory research suggests that St. John's wort may kill or slow the growth of human immunodeficiency virus (HIV), St. John's wort interferes with medications used to treat people with the virus. In addition, it appears that the doses of St. John's wort that would be needed are so high that side effects become intolerable. For now, people with HIV or AIDS should not take St. John's wort.
- Premenstrual syndrome (PMS): An early study suggests that St. John's wort may help relieve physical and emotional symptoms of PMS, including cramps, irritability, food cravings, and breast tenderness.
- Seasonal affective disorder (SAD): Used alone, St. John's wort has improved mood in those suffering from SAD (a type of depression that occurs during the winter months because of lack of sunlight). This condition is usually treated with photo (light) therapy. There is some evidence that using St. John's wort together with phototherapy produces even better results.
- Eczema, wounds, minor burns, hemorrhoids: St. John's wort has antibacterial properties and may also help fight inflammation. Applied topically (to the skin), it may relieve symptoms associated with minor wounds and skin irritation.
- Obsessive compulsive disorder, social phobia: St. John's wort has been proposed as a treatment for these conditions, but two preliminary studies in 2005 showed that the herb was not effective in relieving symptoms.
The use of herbs is a time-honored approach to strengthening the body and treating disease. Herbs, however, can trigger side effects and can interact with other herbs, supplements, or medications. For these reasons, herbs should be taken with care, under the supervision of a health care provider.
St. John's wort is often used to treat depression. If your depression is severe -- causing problems with your daily life or accompanied by thoughts of suicide or of harming yourself or others -- you need to see a doctor immediately. St. John's wort should not be used to treat severe depression.
You should see a doctor to make sure you have the right diagnosis before taking St. John's wort. Your doctor can help you determine the right dose and make sure you are not taking any other medications that might interact with St. John's wort.
Side effects from St. John's wort are generally mild and include stomach upset, hives or other skin rash, fatigue, restlessness, headache, dry mouth, and feelings of dizziness or mental confusion. St. John's wort can also make the skin overly sensitive to sunlight (called photodermatitis). If you have light skin and are taking St. John's wort on a regular basis, be careful about sun exposure. Wear long sleeves and a hat, and use a sunscreen with at least SPF 15 or higher. Avoid sunlamps, tanning booths, and tanning beds.
Because St. John's wort can interact with medications used during surgery, you should stop taking it at least 5 days before surgery. Make sure your doctor and surgeon know you are taking St. John's wort.
Do not take St. John's wort if you have bipolar disorder.
St. John's wort should not be taken by women who are pregnant, trying to become pregnant, or breastfeeding.
St. John's wort interacts with a large number of medications. In most cases, St. John's wort decreases the effectiveness of the medication; in other cases, however, St. John's wort may increase the effects of a medication.
If you are currently being treated with any of the following medications, you should not use St. John's wort without first talking to your doctor:
Antidepressants -- St. John's wort may interact with medications used to treat depression or other mood disorders, including tricyclic antidepressants, SSRIs, and monoamine oxidase inhibitors (MAOIs). Taking St. John's wort with these medications tends to increase side effects, and could potentially lead to a dangerous condition called serotonin syndrome. Do not take St. John's wort with other antidepressants, including:
- SSRIs: Citalopram (Celexa), escitalopram (Lexapro), fluvoxamine (Luvox), paroxetine (Paxil), fluoxetine (Prozac), sertraline (Zoloft)
- Tricyclics: Amitriptyline (Elavil), nortryptyline (Pamelor), imipramine (Tofranil)
- MAOIs: Phenelzine, (Nardil), tranylcypromine (Parnate)
- Nefazodone (Serzone)
Allergy drugs (antihistamines) -- St. John's wort may reduce levels of these drugs in the body, making them less effective:
- Loratadine (Claritin)
- Cetirizine (Zyrtec)
- Fexofenadine (Allegra)
Dextromethorphan (cough medicine) -- When taken at the same time as dextromethorphan, a cough suppressant found in many over-the-counter cough and cold medicines, St. John's wort can increase the risk of side effects, including serotonin syndrome.
Digoxin -- St. John's wort may decrease levels of the medication and reduce its effectiveness. Do not take St. John's wort if you take digoxin.
Drugs that suppress the immune system -- St. John's wort can reduce the effectiveness of these medications, taken after organ transplant or to control autoimmune diseases. In fact, there have been many reports of cyclosporin blood levels dropping in those with a heart or kidney transplant, even leading to rejection of the transplanted organ.
- Adalimumab (Humira)
- Azathioprine (Imuran)
- Cyclosporine
- Etanercept (Enbrel)
- Methotrexate
- Mycophenolate mofetil (CellCept)
- Tacrolimus (Prograf)
Drugs to fight HIV -- St. John's wort appears to interact with at least two kinds of medications used to treat HIV and AIDS: protease inhibitors and non-nucleoside reverse transcriptase inhibitors. The Food and Drug Administration recommends that St. John's wort not be used with any type of antiretroviral medication used to treat HIV or AIDS.
Birth control pills -- There have been reports of breakthrough bleeding in women on birth control pills who were also taking St. John's wort, and it is possible that the herb might interfere with the effectiveness of birth control pills, leading to unplanned pregnancies.
Reserpine -- Based on animal studies, St. John's wort may interfere with reserpine's ability to treat high blood pressure.
Sedatives -- St. John's wort can increase the effect of drugs that have a sedating effect, including:
- Anticonvulsants such as phenytoin (Dilantin) and valproic acid (Depakote)
- Barbiturates
- Benzodiazepines such as alprazolam (Xanax) and diazepam (Valium)
- Drugs to treat insomnia, such as zolpidem (Ambien), zaleplon (Sonata), eszopiclone (Lunesta), and ramelteon (Rozerem)
- Tricyclic antidepressants such as amitriptyline (Elavil)
- Alcohol
Theophylline -- St. John's wort can reduce levels of this medication in the blood. Theophylline is used to open the airways in those suffering from asthma, emphysema, or chronic bronchitis.
Triptans (used to treat migraines) -- St. John's wort can increase the risk of side effects, including serotonin syndrome, when taken with these medications:
- Naratriptan (Amerge)
- Rizatriptan (Maxalt)
- Sumatriptan (Imitrex)
- Zolmitriptan (Zomig)
Warfarin -- St. John's wort reduces the effectiveness of warfarin, an anticoagulant (blood-thinner).
Other drugs -- Because St. John's wort is broken down by certain liver enzymes, it may interact with other drugs that are broken down by the same enzymes. Those drugs may include:
- Antifungal drugs, such as ketoconazole (Nizoral), itraconazole (Sporanox), fluconazole (Diflucan)
- Statins (drugs taken to lower cholesterol)
- Some calcium channel blockers (taken to lower blood pressure)
Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286(2):208-216.
Barrett B, Kiefer D, Rabago D. Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern Ther Health Med. 1999;5(4):40-49.
Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatr Serv. 2000;51(9):1130-1134.
Biffignandi PM, Bilia AR. The growing knowledge of St. John's wort (Hypericum perforatum L) drug interactions and their clinical significance. Curr Ther Res. 2000;61(70):389-394.
Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Newton, MA: Integrative Medicine Communications; 2000:359-366.
Breidenbach T, Hoffmann MW, Becker T, Schlitt H, Klempnauer J. Drug interaction with St. John's wort with cyclosporin. Lancet. 2 000;355:576-577.
Breidenbach T, Kliem V, Burg M, Radermacher J, Hoffman MW, Klempnauer J. Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum) [letter]. Transplantation. 2000;69(10):2229-2230.
Brenner R, Azbel V, Madhusoodanan S, Pawlowska M. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study. Clin Ther. 2000;22(4):411-419.
Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, Ore: Eclectic Medical; 1998:123-125.
Carai MAM, Agabio R, Bombardelli E, et al. Potential use of medicinal plants in the treatment of alcoholism. Fitoterapia. 2000;71:538-542.
De Smet P, Touw D. Safety of St. John's wort (Hypericum perforatum) [letter]. Lancet. 2000;355:575-576.
Ernst E, Rand JI, Barnes J, Stevinson C. Adverse effects profile of the herbal antidepressnat St. John's wort (Hypericum perforatum L.) Eur J Clin Pharmacol. 1998;54:589-594.
Ernst E, Rand JI, Stevinson C. Complementary therapies for depression. Arch Gen Psychiatry. 1998;55:1026-1032.
Ernst E. Second thoughts about safety of St John's wort. Lancet. 1999;354:2014-2015.
Food and Drug Administration. Risk of Drug Interactions with St John's Wort and Indinavir and Other Drugs. Rockville, Md: National Press Office; February 10, 2000. Public Health Advisory.
Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med. 1999;61:712-728.
Gaster B, Holroyd J. St. John's wort for depression. Arch Intern Med. 2000;160:152-156.
Gordon JB. SSRIs and St. John's Wort: possible toxicity? [letter] Am Fam Physician. 1998;57(5):950,953.
Grush LR, Nierenberg A, Keefe B, Cohen LS. St. John's wort during pregnancy [letter]. JAMA. 1998;280(18):1566.
Harrer G. Hypericum and phototherapy. Schweiz Rundsch Med Prax. 2000 Dec 14;89(50):2123-9. Review.
Hubner W-D, Kirste T. Experience with St John's wort (Hypericum perforatum) in children under 12 years with symptoms of depression and psychovegetative disturbances. Phytother Res. 2001;15:367-370.
Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St. John's wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287:1807-1814.
Johne A, Brockmoller J, Bauer S, et al. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin Pharmacol Ther. 1999;66:338-345.
Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial. BMC Med. 2006 Jun 23;4:14.
Khawaja IS, Marotta RF, Lippmann S. Herbal medicines as a factor in delirium. Psychiatr Serv. 1999;50:969-970.
Kim HL, Streltzer J, Goebert D. St. John's wort for depression: a meta-analysis of well-defined clinical trials. J Nerv Ment Dis. 1999;187:532-539.
Kobak KA, Taylor LV, Bystritsky A, Kohlenberg CJ, Greist JH, Tucker P, et al. St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study. Int Clin Psychopharmacol. 2005 Nov;20(6):299-304.
Kobak KA, Taylor LV, Warner G, Futterer R. St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study. J Clin Psychopharmacol. 2005 Feb;25(1):51-8.
Linde K, Mulrow CD. St. John's wort for depression (Cochrane Review). In: The Cochrane Library, Issue 4, 2000. Oxford: Update Software.
Linde K, Ramirez G, Mulrow CD, Pauls A. Weidenhammer W, Melchart D. St. John's wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ. 1996;313:253–257.
Martinez B, Kasper S, Ruhrmann S, Moller HJ. Hypericum in the treatment of seasonal affective disorders. J Geriatr Psychiatry Neurol. 1994;7(Suppl 1):S29–33.
Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998;158(20):2200–2211.
Mischoulon D. Update and critique of natural remedies as antidepressant treatments. Psychiatr Clin North Am. 2007 Mar;30(1):51-68.
Morelli V, Zoorob RJ. Alternative therapies: Part 1. Depression, diabetes, obesity. Am Fam Phys. 2000;62(5):1051-1060.
Nebel A, Schneider BJ, Baker RK, et al. Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother. 1999;33:502.
Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's wort, an herbal preparation in the treatment of depression. J Pharmacol Exp Ther. 2000;294(1):88-95.
O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med. 1998;7(6):523-536.
Phillipp M, Kohnen R, Hiller KO. Hypericum extract versus impramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ. 1999:319(7224):1534-1538.
Piscitelli S, Burstein AH, Chaitt D, et al. Indinavir concentrations and St. John's wort [letter]. Lancet. 2000;355:547-548.
Pizzorno JE, Murray MT. Textbook of Natural Medicine. New York: Churchill Livingstone; 1999:268-269, 797-804.
Robbers JE, Tyler V. Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: The Haworth Herbal Press; 1999:166-170.
Rotblatt M, Ziment I. Evidence-Based Herbal Medicine. Philadelphia, Penn:Hanley & Belfus, Inc. 2002:315-321.
Ruschitzka F, Meier PJ, Turina M, et al. Acute heart transplant rejection due to Saint John's wort [letter]. Lancet. 2000,355.
Sarrell EM, Mandelberg A, Cohen HA. Efficacy of naturopathic extracts in the management of ear pain associated with acute otitis media. Arch Pediatr Adolesc Med. 2001;155:796-799.
Schempp CM, Pelz K, Wittmer A, Schopf E, Simon JC. Antibacterial activity of hyperforin from St. John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria. Lancet. [Research Letters]1999;353:2129.
Schempp CM, Winghofer B, Ludtke R, Simon-Haarhaus B, Shopp E, Simon JC. Topical application of St John's wort (Hypericum perforatum L) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Br J Derm. 2000;142:979-984.
Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol. 2000;15(2):61-68.
Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St. John's wort in major depression: a randomized controlled trial. JAMA. 2001;285(15):1978-1986.
Stevinson C, Ernst E. A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome. British Journal of Obstetrics and Gynaecology. 2000;107:870-876.
Volz HP, Laux P. Potential treatment for subthreshold and mild depression: a comparison of St. John's wort extracts and fluoxetine. Comp Psych. 2000;41(2 Suppl 1):133-137.
Woelk H, for the Remotiv/Imipramine Study Group. Comparison of St. John's wort and imipramine for treating depression: randomized controlled trial. BMJ. 2000;321:536-539.
Wong AH,Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psych. 1998;55(11):1033-1044.
Yue Q, Bergquist C, Gerden B. Safety of St. John's wort (Hypericum perforatum) [letter]. Lancet. 2000;355:576-577.